US 2023/0407241 A1 · A NOVEL PROBIOTIC STREPTOCOCCUS SALIVARIUS STRAIN AND ITS USES

Abstract

The present invention is directed to a novel isolated bacterial strain of the Streptococcus salivahus (S. salivahus) species. More in particular, a strain of the S. salivahus species deposited at BCCM under accession number LMG P-31813. Further, the present invention relates to a composition comprising an isolated bacterial strain of the S. salivahus species. In another aspect, the present invention further relates to the isolated bacterial strain according to the present invention or the composition according to the present invention for use in immunomodulation and/or in the treatment and/or prevention of infections of diseases.

Claims15

Dependent claims

An isolated bacterial strain of the Streptococcus salivarius (S. salivarius) species, said strain deposited at BCCM under accession number LMG P-31813.

Dependencies are inferred from the claim text.

Facts

Application

18/023,805Filed 3 Sep 2021

Priority

EP 20194562.34 Sep 2020

Published

21 Dec 2023

Term ends

Not estimatedThe source records don’t support an estimate.

Classification15 codes

C12N 1/20
Microorganisms; Compositions thereof ; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of…:…
C12N 1/205
Bacteria; Culture media therefor: bacterial isolates
A23L 33/135
Using additives: bacteria or derivatives thereof, e.g. probiotics
A61K 35/74
Microorganisms or materials therefrom: bacteria

A novel probiotic streptococcus salivarius strain and its uses

Life of this patent

A novel probiotic streptococcus salivarius strain and its uses

Life of this patent

Abstract

Claims15